 Connection
Eliza Blanchette to Treatment Outcome
This is a "connection" page, showing publications Eliza Blanchette has written about Treatment Outcome.
|
|
| |
Connection Strength |
|
 |
|
 |
| |
0.077 |
|
|
|
-
Hayde N, Blanchette E, Bock M, Blydt-Hansen T. Outcomes of Steroid Based Versus Steroid Minimizing Immunosuppression in Pediatric Kidney Transplant Recipients: A NAPRTCS Study. Pediatr Transplant. 2025 12; 29(8):e70241.
Score: 0.020
-
Chan M, Blanchette E, Rove KO. Pediatric Patients Undergoing Enterocystoplasty and Risk of Metabolic Disease: A Single Center Retrospective Study. Neurourol Urodyn. 2026 Jan; 45(1):225-230.
Score: 0.020
-
Vincent SA, Cooper E, Easwaran L, Acker SN, Corkum KS, Vemulakonda V, Reynolds R, Varma P, Bock M, Shih V, Blanchette E, Diaz-Miron J. The Use of Extracorporeal Membrane Oxygenation in Neonates With Congenital Renal Failure. J Pediatr Surg. 2025 Nov; 60(11):162597.
Score: 0.020
-
Dharnidharka VR, Scobell RR, Kallash M, Davies AJG, Marchesani N, Maltenfort MG, Walther L, Kelton M, Bock M, Blanchette E, Stone HK, Gluck C, Hullekes F, Riella LV, Smoyer WE, Mitsnefes M, Dixon BP, Flynn JT, Somers MJG, Forrest CB, Furth S, Denburg MR. Clinical characteristics and favorable treatment responses of recurrent focal segmental glomerulosclerosis or steroid-resistant nephrotic syndrome in children after kidney transplantation. Pediatr Nephrol. 2024 11; 39(11):3317-3331.
Score: 0.018
|
Connection Strength
The connection strength for concepts is the sum of the scores for each matching publication.
Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.
|